Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 11,587 | 13,749 | 9,475 | 9,457 | 12,918 |
| Cost of Goods | 3,908 | 4,281 | 3,379 | 3,124 | 3,810 |
| Gross Profit | 7,679 | 9,468 | 6,096 | 6,333 | 9,108 |
| Operating Expenses | 38,604 | 34,052 | 29,518 | 31,853 | 31,446 |
| Operating Income | -30,017 | -24,303 | -23,043 | -25,396 | -21,528 |
| Interest Expense | 2,189 | 2,184 | 6,958 | 3,059 | 3,125 |
| Other Income | 6,140 | 6,133 | 37 | -8 | 585 |
| Pre-tax Income | -26,066 | -20,354 | -29,964 | -28,463 | -24,068 |
| Net Income Continuous | -26,066 | -20,490 | -29,964 | -28,463 | -24,068 |
| Minority Interests | -17,244 | -15,195 | -14,417 | -15,149 | -11,698 |
| Net Income | $-8,822 | $-5,295 | $-15,547 | $-13,314 | $-12,370 |
| EPS Basic Total Ops | -1.65 | -1.05 | -3.00 | -2.85 | -2.85 |
| EPS Basic Continuous Ops | -4.83 | -3.63 | -5.90 | -6.23 | -5.68 |
| EPS Diluted Total Ops | -1.65 | -1.05 | -3.00 | -2.85 | -2.85 |
| EPS Diluted Continuous Ops | -4.83 | -3.63 | -5.90 | -6.23 | -5.68 |
| EBITDA(a) | $-28,106 | $-22,630 | $-17,793 | $-23,404 | $-19,496 |